Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Singapore: A Vibrant Hub for Biomedical Scientists

Published: Friday, December 20, 2013
Last Updated: Friday, December 20, 2013
Bookmark and Share
Ng Siew Kiang, Executive Director for Contact Singapore, discusses the growth of the biomedical sector in Singapore.

Contact Singapore is an alliance of the Singapore Economic Development Board and Ministry of Manpower, which supports professionals and academics from across the globe seeking opportunities to work and live in Singapore. 

Recently, Singapore announced a novel discovery involving the use of nanodiamonds to boost the treatment of chemo-resistant leukaemia. The use of tiny diamonds to facilitate the delivery of drug to leukemic cells was developed by the National University of Singapore (NUS) in partnership with the University of California, Los Angeles (UCLA). In fact, such breakthroughs in areas from cancer and stem cell biology, cardiovascular diseases, diabetes, infectious diseases and neurosciences are commonplace in Singapore. Our research sector is a dynamic, fast-paced environment powered by a community of outstanding scientists and researchers. 

What makes Singapore stand out is our focus on forging collaboration between public and private sector research.  The Biopolis is a shiny beacon of this philosophy. Completed in 2006, this state-of-the-art research facility for biomedical and life sciences houses both public and corporate laboratories, offering unprecedented opportunities for collaboration and the integration of scientific capabilities that has propelled Singapore into a global biomedical sciences hub. 

Another example of knowledge-sharing and communication across different facets of industry is the Academia, an advanced facility which integrates pathology, medical education and research all under the same roof. The 13-storey twin-tower building which opened in July 2013 houses Singapore General Hospital’s pathology services, research laboratories, and education and training facilities of Singapore’s largest healthcare group, SingHealth. 

With such exciting investments come significant opportunities for researchers from all over the world to take up positions in Singapore. 

Singapore has long been at the forefront in supporting and promoting R&D efforts in Asia.  This is demonstrated not only by the calibre of public sector professionals and institutions based here, but also through the government’s active support of private sector research activity from corporate laboratories. 

Already, more than 50 global companies in Singapore are carrying out biomedical sciences R&D, which include drug discovery, translational and clinical research, supported by the government’s commitment to provide £8.3 billion of overall national funding across a range of research disciplines in its latest 5-year master plan ending in 2015.  

Over 6,000 researchers from across the globe currently live and work in Singapore. These companies and individuals have chosen Singapore for its reputation as a vibrant research environment, and because they recognise its potential to grow and develop further in years to come. Aside from a fast-growing research and academic environment, Singapore has a reputation for being one of the world’s most liveable cities, making it an ideal location for overseas professionals looking for a new challenge.

If you’d like to find out more about pursuing career opportunities in Singapore, please visit the link below for more information. 

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos